Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05102617 · ClinicalTrials.gov registry record · NA

Post Market Usability Evaluation Of The PicoSure Pro Device

A NA study of Wrinkle and Acne Scars, sponsored by Cynosure.

Completed
Registry status
NA
Development phase
23
Enrollment target
2
Study locations

NCT05102617 is a NA study of Wrinkle and Acne Scars that has completed, run by Cynosure. The registered enrollment target is 23 participants, below the 119-participant average among 25 other Wrinkle trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05102617, a NA study of Wrinkle and Acne Scars, has completed, sponsored by Cynosure.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
2
Study locations

Study Summary

The intended use of the PicoSure and PicoSure Pro devices used in this study is to treat additional patients with the new PicoSure Pro device and collect additional data on the devices.

Interventions

  • DEVICE PicoSure Pro Device
  • DEVICE PicoSure Device
  • DRUG Topical Cosmeceuticals

Study Locations (2)

California

  • Center for Dermatology and Laser Surgery - Sacramento

Massachusetts

  • Cynosure, Inc. - Westford

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2021-10-21
Est. Completion 2023-03-15
Phase NA

Sponsor

Cynosure

49 total trials

What the Registry Record Tells You About NCT05102617

The ClinicalTrials.gov registry entry for NCT05102617 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 119-participant average among 25 other Wrinkle trials with a reported enrollment target (81% lower). The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Wrinkle appearing as the primary indexed condition, and to 3 interventions - of which PicoSure Pro Device is the first listed.

NCT05102617 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05102617 about?

NCT05102617 is a clinical study titled "Post Market Usability Evaluation Of The PicoSure Pro Device". The intended use of the PicoSure and PicoSure Pro devices used in this study is to treat additional patients with the new PicoSure Pro device and collect additional data on the devices.

What is the current status of trial NCT05102617?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2021-10-21. Estimated completion is 2023-03-15.

What conditions does trial NCT05102617 study?

This clinical trial studies the following conditions: Wrinkle, Acne Scars, Tattoo Removal, Benign Epidermal Pigmented Lesions, Benign Dermal Pigmented Lesions.

What interventions are being tested in trial NCT05102617?

The interventions under investigation include: PicoSure Pro Device (DEVICE), PicoSure Device (DEVICE), Topical Cosmeceuticals (DRUG).

Who is sponsoring clinical trial NCT05102617?

This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05102617 being conducted?

This trial has 2 study locations across California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wrinkle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.